Recruitment

Recruitment Status
Completed
Estimated Enrollment
200

Inclusion Criteria

aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy

Exclusion Criteria

Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding

Summary

Conditions
Chronic Lymphocytic Leukemia
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy
aged >/= 18 years
Diagnosed with first-line CLL having received only 1 cycle of MabThera chemotherapy

Exclusion Criteria

Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding
Receipt of an investigational drug within 30 days prior to entering the study
Pregnant or breast-feeding

Locations

Debrecen, 4032
Veszprem, 8200
Miskolc, 3529
Eger, 3300
Szolnok, 5004
...
Debrecen, 4032
Veszprem, 8200
Miskolc, 3529
Eger, 3300
Szolnok, 5004
Pecs, 7624
Budapest, 1125
Szeged, 6720
Nyíregyháza, 4400
Szombathely, 9700
Székesfehérvár, 8000
Budapest, 1083
Budapest, 1122
Gyula, 5700
Tatabanuya, 2800

Tracking Information

NCT #
NCT02080884
Collaborators
Not Provided
Investigators
Study Director: Clinical Trials Hoffmann-La Roche